Business
DEP cabazitaxel shows complete, sustained tumour regression
DEP cabazitaxel shows complete, sustained tumour regression
About this update from Starpharma Holdings Limited
[{"type":"text","content":"Starpharma Holdings Ltd has released a press release. View Attachment","length":241,"tagName":"div"}]